A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer
Abstract Objective The solute carrier family 25 member 1 (SLC25A1) is currently the only known human transporter for citrate in the mitochondrial membrane. However, its role in cancer development remains to be elucidated. We aim to analyze the expression profile, prognostic value, potential immunolo...
Main Authors: | Xin You, Lingling Huang, Ouxiang Huang, Yujie Deng, Xi Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-11-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-023-00830-z |
Similar Items
-
Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets
by: Yating Liu, et al.
Published: (2024-04-01) -
Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact on glioma progression
by: Wenjie Wu, et al.
Published: (2025-03-01) -
Pan-Cancer Analysis of the Oncogenic and Immunological Role of Solute Carrier Family 6 Member 8 (SLC6A8)
by: Xin Yang, et al.
Published: (2022-08-01) -
SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients
by: Fangshu Liu, et al.
Published: (2023-01-01) -
Comprehensive investigation in oncogenic functions and immunological roles of NCBP2 and its validation in prostate cancer
by: Jian Wang, et al.
Published: (2024-09-01)